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ABSTRACT
In autosomal dominant polycystic kidney disease (ADPKD), cyst
inflation and continuous enlargement are associated with marked
transepithelial ion and fluid secretion into the cyst lumen via cystic
fibrosis transmembrane conductance regulator (CFTR). Indeed, the
inhibition or degradation of CFTR prevents the fluid accumulation
within cysts. The in vivomechanisms bywhich the lack of Polycystin-2
leads to CFTR stimulation are an outstanding challenge in ADPKD
research and may bring important biomarkers for the disease.
However, hampering their study, the available ADPKD in vitro
cellular models lack the three-dimensional architecture of renal
cysts and the ADPKD mouse models offer limited access for live-
imaging experiments in embryonic kidneys. Here, we tested the
zebrafish Kupffer’s vesicle (KV) as an alternative model-organ. KV is
a fluid-filled vesicular organ, lined by epithelial cells that express both
CFTR and Polycystin-2 endogenously, being each of them easily
knocked-down. Our data on the intracellular distribution of Polycystin-
2 support its involvement in the KV fluid-flow induced Ca2+-signalling.
Mirroring kidney cysts, the KV lumen inflation is dependent on CFTR
activity and, as we clearly show, the knockdown of Polycystin-2
results in larger KV lumens through overstimulation of CFTR. In
conclusion, we propose the zebrafish KV as a model organ to study
the renal cyst inflation. Favouring its use, KV volume can be easily
determined by in vivo imaging offering a live readout for screening
compounds and genes that may prevent cyst enlargement through
CFTR inhibition.
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INTRODUCTION
The major clinical manifestation of autosomal dominant polycystic
kidney disease (ADPKD) is the development of massive fluid-filled
kidney cysts that destroy the renal parenchyma. ADPKD has no
treatment and no biomarkers to predict renal function decline.
Nowadays, patients are still managed with supportive measures
only, namely analgesics, antibiotics for cyst infection, blood
pressure control and avoidance of caffeine and oestrogens. About
50% of ADPKD patients reach end-stage renal disease by age 60,
requiring dialysis and renal replacement therapy (Patel et al., 2009;
Wallace, 2011).
ADPKD is the most common genetic cause and the fourth leading
cause of kidney failure, affecting 1 in 400–1000 newborns.
Mutations in the genes encoding Polycystin-1 ( pkd1, OMIM-
601313) and Polycystin-2 ( pkd2, OMIM-613095) in Online
Mendelian Inheritance of Man (http://www.ncbi.nlm.nih.gov/
omim), account for all known forms of the disease (Cornec-Le
Gall et al., 2013). Both genes present high level of allelic
heterogeneity, with hundreds of reported mutations expected to
range from loss of function to hypomorphic variants (http://pkdb.
mayo.edu/). Polycystin-1 and 2 are transmembrane glycoproteins of
4302 and 968 amino acids, respectively. While Polycystin-1 has
structural features of a mechanosensor (Hughes et al., 1995), its
binding partner Polycystin-2 is a non-selective Ca2+-conducting
channel (González-Perrett et al., 2001). These are expected to
assemble together into a mechanosensor-channel complex in the
membrane of primary cilia of kidney epithelial cells (Nauli et al.,
2003). Although the precise function of this complex is still
unresolved, it has been suggested that the urine-flow is sensed by
Polycystin-1 and transduced into a ciliary Ca2+-signal by
Polycystin-2 (Nauli et al., 2003; Praetorius and Spring, 2001). As
shown by in vitro experiments, this ciliary Ca2+ wave is propagated
and amplified in the cytoplasm, a process that depends on
Polycystin-2 expressed at the endoplasmic reticulum (ER) (Jin
et al., 2014; Nauli et al., 2003; Praetorius and Spring, 2001; Xu
et al., 2007). The role of Polycystin-2 in Ca2+ homeostasis is
essential for the differentiation and maintenance of the kidney
tubular epithelium. Once disrupted, as in ADPKD cells, a reduction
in basal intracellular Ca2+ levels occurs, which is thought to trigger
cystogenesis (Spirli et al., 2012; Yamaguchi et al., 2006).
ADPKD cysts are anatomically separated from the tubule from
which they derive (Grantham et al., 1987). While the normal renal
tubule epithelium has mainly absorptive properties (for glomerular-
filtrated reabsorption), cyst-lining cells have abnormally high
capacity of ion and fluid secretion into the cyst lumen. This
entails marked modifications in the activity of ion-channels.
Activation of cystic fibrosis transmembrane conductance regulator
(CFTR) plays a central role in this process. Triggering Cl− and water
secretion towards the cyst lumen, CFTR promotes cyst inflation
(Torres and Harris, 2014). As it is a key Cl− channel for regulating
epithelial ion and fluid transport, the loss of CFTR (OMIM-602421)
underlies cystic fibrosis (CF), a recessive disease characterized by
mucus build-up in several organs (Amaral and Farinha, 2013). In
contrast to ADPKD, CF patients do not have major renal problems.
Perhaps because kidney tissue from healthy individuals have low
levels of CFTR (Hanaoka et al., 1996), also supported by the
evidence that ectopic expression of Polycystin-1 reduces its apicalReceived 14 August 2015; Accepted 31 August 2015
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expression in mammalian kidney cells (Ikeda et al., 2006).
Highlighting its involvement in ADPKD, Hanaoka et al. reported
a strong expression of CFTR in cyst-lining cells from ADPKD
patients and shown that fluid accumulation within cysts involves
CFTR-like Cl− currents (Hanaoka et al., 1996). Further evidence
comes from the cyst inflation being slowed down either through
pharmacological inhibition of CFTR or by reducing its apical
expression in cyst-lining cells (Blazer-Yost et al., 2010; Li et al.,
2004, 2012; Yang et al., 2008; Yuajit et al., 2013, 2014). Also, a
milder renal disease was observed in few patients affected
simultaneously by ADPKD and CF (Xu et al., 2006).
Not much is known about the molecular mechanisms behind the
activation of CFTR in cyst epithelial cells. Converging data support
the hypothesis that it may result from the impairment of the 3′,5′-
cyclic adenosine monophosphate (cAMP) homeostasis. Increased
intracellular cAMP levels are among the most consistently
described changes associated with ADPKD. Indeed, vasopressin
and forskolin exacerbate renal cyst growth via increasing
intracellular cAMP levels (Wallace, 2011). In contrast, Tolvaptan,
a vasopressin V2 receptor antagonist, slows down cystogenesis by
lowering the levels of this second messenger (Reif et al., 2011;
Torres et al., 2012). It is thought that the combination of increased
production and decreased degradation of cAMP raises its basal
concentration to levels closer to the threshold for Protein kinase A
(PKA) activation, leading to CFTR stimulation. Indeed, CFTR
stimulation requires its prior cAMP-dependent phosphorylation by
PKA (Amaral and Farinha, 2013).
The role of CFTR in ADPKD has been approached using in vitro
cellular models such as Madin–Darby canine kidney (MDCK) cells
(Li et al., 2004, 2012; Yuajit et al., 2013) and ADPKD cyst-derived
cell lines (Reif et al., 2011). These cellular models form cyst-like
structures when grown in a collagen matrix, lacking, however, the
three-dimensional architecture of renal cysts. The effectiveness of
CFTR-interfering drugs in preventing cystogenesis has also been
demonstrated usingADPKDmousemodels (Blazer-Yost et al., 2010;
Yang et al., 2008; Yuajit et al., 2014). However, the limited access to
the kidneys of mouse embryos at early developmental stages, namely
for live-imaging experiments, hinders their widespread use to study
the precise mechanisms underlying the CFTR stimulation.
The zebrafish mutant for the orthologous gene of human pkd2,
the curly-up (cup−/−) mutant has emerged as a model-organism to
study cardiovascular problems (Paavola et al., 2013), organ
laterality (Schottenfeld et al., 2007) and midline axis defects (Le
Corre et al., 2014). However, limiting its usage to study the ADPKD
cystogenesis, cup−/−mutants do not develop kidney cysts, probably
because of the maternal contribution of pkd2mRNA present during
early embryonic stages (Schottenfeld et al., 2007; Sun et al., 2004).
Alternatively, the injection of morpholinos against pkd2 mRNA to
specifically knockdown its translation from one-cell stage induces
pronephric cysts (Obara et al., 2006; Schottenfeld et al., 2007; Sun
et al., 2004). However, while impairing the fluid homeostasis of the
animal, these cysts were mainly pronephric dilations that never get
to bud off from the tubules, thus, not recapitulating the vesicular
architecture of the ADPKD patients’ cysts.
Aiming to overcome the imperfect fish model, we investigated
the usefulness of zebrafish Kupffer’s vesicle (KV) as a model organ
for kidney cyst inflation. The KV is an organ transiently present in
the normal early embryonic life of the fish to establish internal body
laterality (Essner et al., 2005; Sampaio et al., 2014; Smith et al.,
2014). It derives from the dorsal forerunner cells (DFCs) that cluster
at the tailbud of the embryo (Essner et al., 2005; Sampaio et al.,
2014; Smith et al., 2014). Although not being a renal-related organ,
the KV is a fluid-filled vesicle (Fig. 1A) which inflation depends on
CFTR (Navis et al., 2013). It is lined by epithelial cells that express
both CFTR (Navis et al., 2013) and, as we show here, Polycystin-2.
While not affecting cell proliferation which is a marked difference to
the renal cyst formation, we demonstrate that pkd2-knockdown
causes a significant increase in the CFTR-mediated fluid-secretion
into the KV lumen mirroring the cyst inflation process. We, thus,
propose the zebrafish KV as a model organ to study the stimulation
of CFTR in ADPKD.
RESULTS
pkd2 and cftr are expressed in KV-lining cells
Previous studies have reported the presence of pkd2 and cftr
transcripts in the early stages of the zebrafish embryonic
development (Bisgrove et al., 2005; Navis et al., 2013; Obara
et al., 2006; Schottenfeld et al., 2007). Our in situ hybridization
experiments, using different mRNA probes from those used in the
mentioned studies, showed that at the 10–11somite stages (s.s.)
pkd2 and cftr are expressed in the same tissues of the embryo.
Corroborating those studies, we detected both transcripts in the KV
region (Fig. 1B,C) (Bisgrove et al., 2005; Navis et al., 2013;
Schottenfeld et al., 2007). We also detected pkd2 expression in the
brain and in the neural floorplate as before (Bisgrove et al., 2005;
Schottenfeld et al., 2007) and, less intensely, in the primordia of the
pronephric ducts (Fig. 1B). Interestingly, we show here an identical
pattern of expression for cftr transcripts (Fig. 1C).
To characterize the expression of Polycystin-2 in zebrafish KV,
we performed whole-mount immunostaining in 10–11 s.s.
wild-type (WT) embryos. Polycystin-2 was detected through the
KV-lining cells, with a punctate pattern of expression (Fig. 1D),
many times clustered near the nuclei (Fig. 1F). Given the similarity
to the pattern described for Polycystin-2 in zebrafish pronephros (Fu
et al., 2008; Obara et al., 2006) and in mouse (Gainullin et al., 2015;
Pazour et al., 2002) and human kidney cells (Cai et al., 1999;
Gainullin et al., 2015; Hofherr et al., 2014), we speculate that these
clusters may correspond to the Polycystin-2 expressed at the ER
membrane.We also found Polycystin-2 along the zebrafish KV cilia,
co-localizing with acetylated α-tubulin (Fig. 1E-G), in complete
agreement to the ciliary expression described for medaka KV cells
(Kamura et al., 2011) and for zebrafish, mouse and human renal cells
(Gainullin et al., 2015; Obara et al., 2006; Pazour et al., 2002). Obara
et al. have also suggested the presence of Polycystin-2 at the base of
zebrafish pronepheric cilia (Obara et al., 2006). Here, we clearly
show that, indeed, Polycystin-2 is expressed at the basal body of the
KV cilia, co-localizing with γ-tubulin (Fig. 1H-K).
Supporting the efficient knockdown of Polycystin-2, we were
able to reduce its immunodetection by injecting one-cell stage
embryos with 1.8 ng of pkd2-augMO (Fig. 1L). Indeed, the
Polycystin-2 signal along the cilia was totally abolished
(Fig. 1M-O) and, although we still detected it at the base of the
cilia (Fig. 1P-S), its cytoplasmic signal was considerably lowered
(Fig. 1L-O). This reduction was sufficient to induce a curly-up tail
phenotype (Fig. 1T,U) and heart position defects (54% of right-sided
or central hearts) (Fig. 1V), comparable to those obtained by others
(Schottenfeld et al., 2007).
Regarding CFTR, Navis et al. have recently described a strong
expression of this protein at the apical membrane of the cells facing
the lumen of the zebrafish KV (Navis et al., 2013).
pkd2-knockdown impacts on the KV volume
In order to determine whether Polycystin-2 and CFTR have a similar
relationship in theKV-lining cells to that observed inADPKDcysts,we
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determined the impact of the knockdown of pkd2 on the KV volume.
For that, we scanned thewholeKVby confocal live-microscopyof ras:
GFP transgenic embryos at the 10–11 s.s. As demonstrated by the
middle focal plan and respective orthogonal views, pkd2-morphants
presented KVs with significant larger dimensions than their WT
siblings or pkd2-mismatch MO injected embryos (Fig. 2A,B,C). On
average pkd2-morphants presented KVs with 1.6 times the volume of
WT siblings and 1.4 times the volume of the pkd2-mismatch MO
Fig. 1. Polycystin-2 andCFTRexpression. (A) Localization of KV (squared region) in the body of a 10–11 s.s. zebrafish embryo. (B,C) RNA in situ hybridizations
for pkd2 (B) and cftr (C) in 10–11 s.s. WT embryos. Both pkd2 and cftr transcripts are detected in the KV region (right squares), neural floorplate
(arrow heads), brain and pronephric ducts primordia (arrows). (D-S) Confocal images for the immunolocalization of Polycystin-2 in KV cells at the 10–11 s.s. InWT
embryos (D-K), Polycystin-2 is detected clustered near the nuclei (white arrow in F), along cilia (white arrow heads in F) and at the basal body (dashed arrows in
H,J andK). In pkd2-morphants (L-S), the Polycystin-2 signal ismarkedly reduced and, although still detected at the basal body (dashed arrow in P,R andS), it is no
longer detected along cilia. (D,L) maximal intensity z-stack projection; (E-K;M-S) z-section. Polycystin-2 (green), acetylated α-tubulin (red), γ-tubulin, (purple),
nuclei (blue). Scale bars: 10 µm. (T,U) Lateral view of pkd2-morphant (T) and WT (U) larvae at 72 hpf. (V) Heart position defects: pkd2-morphants – 33% right-
sided, 21% central; cftr-morphants – 21% right-sided, 17% central; andWT siblings – 0.7% right-sided, 1.0% central. Left-sided (light grey), central (dark grey) and
right-sided hearts (black). n, number of scored embryos.
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injected controls (pkd2-morphant KVvolume=92×103±23×103 µm3 vs
WT KVvolume=59×103±24×103 µm3 with P=0.0017 or vs pkd2-
mismatch MO KVvolume=66×103±29×103 µm3 with P=0.0289)
(Fig. 2K). WT and pkd2-mismatch MO KVs were equivalent
(Fig. 2A,C,K). Similar results were obtained in embryos at the
8–9 s.s. (data not shown).
To determine the cause behind this observation, we counted
the number of cells and cilia lining the KV of pkd2-morphants. As
both parameters were equivalent to those of their WT siblings
(Fig. 3A,B), we demonstrated that the knockdown of pkd2 was not
affecting KV cell proliferation. Therefore, our data were suggesting
that reduction of Polycystin-2 protein levels drives increased fluid
secretion into the KV lumen. In that case, changes in the shape of
the cells facing the KV lumen would be expected. Indeed, the
growth of the KV lumen through enhanced fluid secretion increases
the KV intraluminal pressure and drives regional cell shape
modifications (Compagnon et al., 2014). To clarify this, we
assessed the shape of the cells from the anterior and posterior
regions of pkd2-morphant and WT KVs (Fig. 3C-E). While not
affecting the cells’ width, the knockdown of pkd2 significantly
increased the cells’ height both anteriorly and posteriorly (Fig. 3C).
Moreover, it also affected significantly the cells’ length. Thus, cells
Fig. 2. KV volume. (A-J) Confocal live-microscopy scans of the whole KV of 10–11 s.s. ras:GFP transgenic embryos. The middle focal plane along the xy axis
and the respective orthogonal views (along xz and yz axes) are shown for the most representative WT (A), pkd2-morphant (B), pkd2-mismatch MO (C),
0.14% (v/v) DMSO-treated WT (D), cftr-morphant (E), double-morphant (F), 30 µM CFTRinh-172-treated WT (G) and pkd2-morphant (H), and 10 µM forskolin
+40 µM IBMX-treated WT (I) and pkd2-morphant (J) embryos. C is a control for B. D is a control for G,H,I and J. KVvolume is indicated in µm3 and in picol.
Scale bars: 10 µm. (K) Estimated KV volumes (µm3) for WT (n=16), pkd2-mismatch MO (n=12), pkd2-morphant (n=11), cftr-morphant (n=8), double-morphant
(n=6), 0.14% (v/v) DMSO-treated WT (n=10), 30 µM CFTRinh-172-treated WT (n=10) and pkd2-morphant (n=10), 10 µM forskolin+40 µM IBMX-treated WT
(n=11) and pkd2-morphant (n=12) embryos.Mean±s.d.; ψP≤0.05 and ψψP<0.0001, significantly different fromWT; *P<0.05 and **P<0.0001, significantly different
from pkd2-morphants.
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became shorter at the KV anterior part and longer at the posterior
region (Fig. 3C,E). Supporting our hypothesis, those differences are
translated in the increase of the apical surface of the cells facing the
KV lumen posteriorly (P<0.01) (Fig. 3D).
We also assessed the KV volume of the progeny of the cup+/−;
foxj1a:GFP parents. At the 10–11 s.s., the foxj1a:GFP transgene
allows the detection of KV-lining cells (Fig. S1). The cuptc321 is
likely to be a null mutation and, when in homozygosity, it causes
severe curly-up tail phenotypes and organ laterality defects, limiting
the larvae survival (Schottenfeld et al., 2007). In our experiments,
after having imaged the KVs from the progeny of the cup+/−;foxj1a:
GFP parents, we allowed the embryos to grow until 72 hpf
(hours post-fertilization) to distinguish the cup−/− mutants by
their curly-up tails. On average the curly-up tail embryos presented
KVs that were larger than their normal tail siblings (Fig. S1A,B).
However, this difference was not statistically significant, nor as
pronounced as that observed when comparing pkd2-morphant with
WT siblings (Fig. S1C). This can be easily explained by the
maternal contribution of pkd2 mRNA previously detected in the
early stages of the cup mutants’ embryonic life (Schottenfeld et al.,
2007). Corroborating this data, our whole-mount immunostaining
experiments showed that, although in a less extent than in their
normal tail siblings (Fig. S1D-G), at 36 hpf Polycystin-2 is still
present near the basal body and along the pronephric cilia from
curly up tail cup−/− mutants (Fig. S1H-J). This effect must be
undoubtedly more pronounced at earlier stages of development,
during the KV life time. Also masking the differences in terms of
KV volume is the fact that the group of normal tail embryos displays
more variability because it gathers both cup+/− and cup+/+ siblings.
In conclusion, the cup mutant zebrafish line is not useful for the
purpose of this work. A maternal zygotic may be considered as an
alternative for future experiments.
CFTR has a role in the enlargement of the KV after pkd2-
knockdown
Navis et al. have described that CFTR is essential for the proper KV
inflation (Navis et al., 2013). Efficiently phenocoping cftr-mutants,
injection of 1.6 ng of cftr-augMO severely impaired the lumen
Fig. 3. KV-lining cells. (A) Number of
cells counted in the whole KV live-
microscopy scans of 10–11 s.s. WT
(n=14) and pkd2-morphant (n=10)
embryos. (B) Number of cilia counted in
WT (n=6) and pkd2-morphant (n=6)
embryos immunodetected for
acetylated α-tubulin. (C) Cellular length,
width and height of WT (n=6) and pkd2-
morphant (n=11) embryos
immunodetected for actin cytoskeleton.
The box plot and the respective max
and min values are indicated. *P<0.01
and **P<0.0001, significantly different
from WT. (D) Estimated apical surface
area of KV-lining cells. (E) Schematic
representation of cell shape of WT and
pkd2-morphant KVs.
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expansion of the KV (cftr-morphants KVvolume=7×103±4×103 µm3
vs WT KVvolume=59×103±24×103 µm3; P<0.0001) (Fig. 2A,E,K).
Thus, presenting KVs with 12% of the volume of their WT siblings
(Fig. 2E), cftr-morphants have KV functional problems that justify
the observed heart position defects (38% of right-sided or central
hearts) (Fig. 1V).
In order to test whether the enlargement of the KV volume of the
pkd2-morphants was reflecting an enhancement of the CFTR-
dependent fluid secretion, we injected embryos at their one-cell stage
with both morpholinos (pkd2-augMO and cftr-augMO) expecting to
neutralize that effect. We tried to titrate the amount of cftr-augMO in
order to bring the KV luminal volume of double-morphants to WT
values. However, by injecting as low as 0.1 ng (14 times less than in
cftr-morphants), we still observed an almost complete failure of KV
lumen expansion (Fig. 2F,K). This suggests that the downregulation
of cftr overrides the effect of downregulating pkd2.
This prompted us to address the role of CFTR in the KV inflation
of the pkd2-morphants by pharmacological manipulation of the
CFTR activity. Indeed, Navis et al. showed that the KV luminal
area can be regulated by the pharmacological modulation of CFTR
activity (Navis et al., 2013). We treated embryos with 5 µM ouabain
solution from 6 to 10 s.s., a shorter time window than that used by
those authors. WT embryos under this treatment presented a non-
significant reduction in their KV volume (ouabain treated
WT KVvolume=44×103±24×103 µm3 vs WT KVvolume=59×103±
24×103 µm3; P>0.05) (Fig. S2). On the other hand, when we treated
pkd2-morphant embryos using the same conditions, this was
sufficient to reduce the volume of their KVs to WT values, i.e.
significantly lower than those of non-treated pkd2-morphants
(ouabain treated pkd2-morphants KVvolume=56×103±26×103 µm3
vs pkd2-morphants KVvolume=92×103±23×103 µm3; P=0.0013)
(Fig. S2). However, a major drawback of ouabain is the fact that it is
not specific for CFTR. Actually, this molecule exerts its action on
CFTR by inhibiting Na+/K+-ATPase, a pump that supports the ion
gradient between the intra- and the extracellular space, which is
essential for CFTR activity (Lingrel, 2010). The inhibition of this
central ATPase is, therefore, highly promiscuous, potentially
affecting nearly all cellular transport. Therefore, we gave a step
forward and tested the effect of a specific inhibitor of CFTR,
thiazolidinone (CFTRinh-172), which was shown to slow down in
vitro cyst enlargement (Li et al., 2004). By treating WT embryos
with 30 µM CFTRinh-172 solution from 6 s.s. onwards, a
significant reduction in their KV volume was observed
(CFTRinh-172 treated WT KVvolume=35×103±20×103 µm3 vs WT
KVvolume=59×103±24×103 µm3; P=0.0132) (Fig. 2A,G,K).
Interestingly, pkd2-morphant embryos under the same conditions
presented an even more pronounced reduction of their KV
luminal volume. This was significantly lower than those of
non-treated pkd2-morphants (CFTRinh-172 treated pkd2-morphants
KVvolume=35×103±27×103 µm3 vs pkd2-morphants KVvolume=92×
103±23×103 µm3; P<0.0001) and those of WT embryos (CFTRinh-
172 treated pkd2-morphants vs WT KVvolume=59×103±
24×103 µm3; P=0.0034) (Fig. 2A,B,H,K). DMSO 0.14% (w/v)
had no effect in KV volume (Fig. 2D,K).
To activate CFTR, we treated embryos with a cocktail of
10 µM forskolin+40 µM IBMX from 6 to 10 s.s., also a shorter time
window than that used by Navis et al. (2013). The results showed
that forskolin+IBMX treated WT embryos presented a significant
increase in the KV volume, showing on average KVs with
1.6 times the volume of WT siblings (forskolin+IBMX treated
WT embryos KVvolume=94×103±45×103 µm3 vs WT KVvolume=
59×103±24×103 µm3; P=0.00321) (Fig. 2A,I,K). It is important to
mention that Navis et al. showed that forskolin+IBMX failed to
rescue the KV lumen expansion of zebrafish embryos homozygous
for cftrpd1049 allele (null mutants). This clearly demonstrates that the
forskolin+IBMX stimulated KV fluid secretion is mediated by
CFTR. The next step was to expose the pkd2-morphants to the
forskolin+IBMX treatment. We expected them to have at least, 3.2
times the volume of WT siblings, i.e. 1.6 times from the pkd2-
augMO effect plus 1.6 times from the forskolin+IBMX effect.
Interestingly, a synergistic effect between these two factors was
observed with forskolin+IBMX treated pkd2-morphants presenting,
on average, KVs with 3.6 times the volume of WT siblings
(forskolin+IBMX treated pkd2-morphants KVvolume=215×103±
70×103 µm3 vs pkd2-morphants KVvolume=92×103±23×103 µm3;
P<0.0001) (Fig. 2B,J,K). This indicated that these two factors
synergistically activate CFTR.
Is this crosstalk between the lack of Polycystin-2 and the
stimulation of CFTR a cell autonomous process? To answer this
question we targeted the pkd2-knockdown into the DFCs (Essner
et al., 2005). This time we assessed the KV volume by scanning the
whole organ in embryos immunostained for actin cystoskeleton at
the 8–10 s.s. Our data clearly show that increasing amounts of
morpholino lead to a gradual dilation of the KV (Fig. S3). Indeed,
while observing a very small effect when injecting 4 ng, a
significant dilation was observed when using 9 ng. These data
supports the hypothesis that, although being expressed in KV
surrounding tissues, it is the specific knockdown of Polycystin-2 in
the KV cells that leads to CFTR stimulation. The possible mosaic
uptake of the morpholino, a recurrent problem in this approach
(Essner et al., 2005), may justify the requirement of such high
amounts of pkd2-augMO to induce the KV dilation.
Inflation dynamics of the pkd2-morphant KV
Navis et al. showed that the apical expression of CFTR in the cells
facing the lumen of the KVwas detected from the very beginning of its
lumen formation, i.e. from 1 s.s. (Navis et al., 2013). So, we next
evaluated at what stage did the volume started to increase upon the
Polycystin-2 knockdown. For thatwe followed the live-dynamics of the
KV inflation in pkd2-morphants and WT embryos (Fig. 4). We
observed that in both cases the KV inflation rate was the same until the
2 s.s. (Fig. 4A,B,C,F,G). It was only at the 3 s.s. that the rate of inflation
of the KVs from pkd2-morphants increased and became significantly
different from WT embryos (Fig. 4A,D,H). This suggests that the
overstimulation of CFTR upon the knockdown of Polycystin-2 occurs
early in theKVmorphogenesis, but not immediately after its formation.
DISCUSSION
Through largely unknown mechanisms, ADPKD cystogenesis
involves two major steps: the formation of the cyst, which
requires aberrant proliferation of tubule epithelial cells; and the
cyst inflation, that requires marked transepithelial fluid secretion
towards the cyst lumen (Wallace, 2011).
Numerous studies using cellular (Li et al., 2004, 2012; Reif et al.,
2011; Yuajit et al., 2013) or mousemodels for ADPKD (Blazer-Yost
et al., 2010; Yang et al., 2008; Yuajit et al., 2014) have proved the
key role of CFTR in the cyst inflation process. This can be slowed
down by the use of CFTR-interfering molecules, such as: steviol and
its derivatives that inhibit CFTR and promote its proteasome-
mediated degradation (Yuajit et al., 2013, 2014); CFTRinh-172 (Li
et al., 2004), the CFTR blocker used in our experiments; and
pioglitazone, an agonist of the peroxisome proliferator-activated
receptor γwhich reduces the CFTRmRNA levels (Blazer-Yost et al.,
2010). The overexpression of the commonest mutation associated to
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CF, F508del, where the protein fails in reaching the cell membrane,
was also shown to slow in vitro cystogenesis (Li et al., 2012).
The available ADPKD model systems, although useful in testing
the effectiveness of those molecules, are limited in the study of the
precise mechanisms by which the lack of Polycystin-2 leads to
CFTR stimulation. In our perspective, such model system must
fulfil some requirements: (1) it should have a fluid-filled vesicular
structure resembling the architecture of ADPKD renal cysts; (2) it
should be lined with ciliated cells, since cells facing the lumen of
ADPKD kidney cysts are ciliated (Thomson et al., 2003; Xu et al.,
2007); (3) these cells should endogenously express both CFTR and
Polycystin-2 and the system should allow the easy knockdown of
each of them; (4) under normal conditions, it should exhibit a fluid-
flow induced Ca2+-signaling mediated by Polycystin-2, which
should be impaired in the absence of Polysystin-2; (5) its lumen
inflation should be dependent on CFTR; and, most importantly (6)
the lack of Polycystin-2 should result in larger volumes through
stimulation of CFTR. Based on our findings and hypotheses we
propose the zebrafish KV to be that model-organ (Fig. 5).
KV has a cyst-like structure
KV is a fluid-filled enclosed cavity, lined by monociliated epithelial
cells. It forms during early somitogenesis at the posterior end of
the embryo from the DFCs cluster and is transiently present from 1
to 14 somites (Essner et al., 2005). The relative simplicity and
experimental accessibility of KV compared with other organs
undergoing de novo lumen formation make it an attractive model-
organ. Indeed, during the time window of KV existence, embryos
are fully transparent allowing the easy access to the KV volume by
confocal live-microscopy of ras:GFP or foxji1:GFP transgenic
embryos.
KV cells express both CFTR and Polycystin-2
At the 10–11 s.s., we detected both cftr and pkd2 transcripts in the
KV region. Regarding pkd2 expression, our results are in line with
previous studies that reported marked expression of pkd2 transcripts
in the zebrafish DFCs during gastrulation, that become more diffuse
as these cells form the KV (Bisgrove et al., 2005; Schottenfeld et al.,
2007). Regarding cftr expression, our data are in line with Navis
et al., who have reported an enrichment of these transcripts in
zebrafish KV at the 3 s.s. that also turned to be more diffuse as
somitogenesis proceeded (Navis et al., 2013). At the protein level,
those authors showed the apical expression of CFTR in cells lining
the KV (Navis et al., 2013) and we show here, that these cells also
express Polycystin-2.
The intracellular distribution of Polycystin-2 supports its
involvement in the KV fluid-flow induced Ca2+-signalling
We found Polycystin-2 distributed through the cytoplasm, many
times clustered near the nuclei. This is in agreement with the
literature that describes ER as the major location for Polycystin-2
within zebrafish, mouse and human cells (Cai et al., 1999; Fu et al.,
2008; Gainullin et al., 2015; Hofherr et al., 2014; Pazour et al.,
2002). Indeed, Polycystin-2 has a conserved ER retrieval motif, a
cluster of acidic amino acids at its C-terminal, also present in the
zebrafish orthologue (Fu et al., 2008). It has been suggested,
however, that a balanced subcellular compartmentalization of
endogenous Polycystin-2 is important for the proper functioning
of the zebrafish KV in the left-right axis determination (Fu et al.,
2008). In accordance, we also detected Polycystin-2 along all KV
cilia, recapitulating the expression pattern observed in medaka KV
(Kamura et al., 2011), zebrafish pronephros (Obara et al., 2006) and
mouse and human renal cells (Gainullin et al., 2015; Pazour et al.,
2002).
The intracellular distribution of Polycystin-2 corroborates its
involvement in Ca2+ transients recently demonstrated to occur
within zebrafish KV (Yuan et al., 2015). Accordingly, as KV cilia
acquire motility become capable of generating a fluid-flow within
the lumen of the organ. This fluid-flow triggers Polycystin-2-
dependent intraciliary Ca2+ oscillations which are subsequently
transduced into cytosolic Ca2+ waves (Yuan et al., 2015), as
represented in Fig. 5B. In this way, a Ca2+-signaling pathway of
unknown effectors is initiated to control the subsequent events
necessary for the correct organ positioning in the embryo (Yuan
et al., 2015). This brings the KV epithelium closer to the normal
renal tubular epithelium. Indeed, the urine flow triggers a
Polycystin-2-mediated ciliary Ca2+ signaling in the human tubular
epithelial cells, which is essential for the maintenance and
Fig. 4. KV inflation live-dynamics. (A) KV luminal area of pkd2-morphants
and WT embryos measured along development from 1 to 4 s.s. For each time
point mean±s.d. are indicated. Number of tested embryos: WT, n=11; pkd2-
morphant, n=8. ψP<0.05, significantly different from the previous time point in
pkd2-morphants; *P<0.05, significantly different fromWT at the corresponding
time point. (B-I) Bright field images captured for the same embryo along
development are shown for the most representative WT (B-E) and pkd2-
morphant (F-I). Scale bars: 10 µm.
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differentiation of the renal tissue. In vitro cell based experiments
have demonstrated that in response to a fluid shear stress, a
Polycystin-2-dependent ciliary Ca2+ influx occurs, driving a Ca2+
release from ER stores (Jin et al., 2014; Nauli et al., 2003; Praetorius
and Spring, 2001; Xu et al., 2007). We should highlight, however,
that we are not bringing KV cilia close to kidney cilia in terms of
their structure or function. Indeed, these differ in many ways. Cilia
from normal kidney cells are immotile and do not generate flow.
Although not much is known about cilia from kidney cysts, it is
plausible that these differ from the primary cilia present in the
normal tubular epithelia (Thomson et al., 2003; Xu et al., 2007).
cftrandpkd2expression areeasily knockeddown inKVcells
Supporting the efficient knockdown of CFTR and Polycystin-2, both
the cftr-augMO and the pkd2-augMO induced heart position defects,
phenocopying the previously described cftr and cup−/− zebrafish
mutants, respectively (Navis et al., 2013; Schottenfeld et al., 2007).
To our knowledge, laterality problems caused by the lack of CFTR
were never reported inCF patients, possibly because the use ofCFTR
in the left-right organizer might be a teleost specific mechanism.
Mirroring kidney cysts, Polycystin-2 was no longer detected
along pkd2-morphants KV cilia. Indeed, the cilia of ADPKD kidney
cysts epithelial cells lack the expression of Polycystin-1, -2 or both
(Xu et al., 2007). Additionally, pkd2-morphants showed a marked
reduction in the cytoplasmic levels of the immunodetected
Polycystin-2. A more accurate quantification of the knockdown
efficiency was hampered by the fact that all the commercially
available antibodies against mammalian Polycystin-2 that we have
tested failed in detecting the protein by western blot. Nevertheless,
as represented in Fig. 5D, it was recently shown that the knockdown
of Polycystin-2 with the same pkd2-augMO used in our experiments
suppresses, in number and amplitude, the intraciliary Ca2+
oscillations and the subsequent cytoplasmic Ca2+ waves in KV-
lining cells (Yuan et al., 2015).
Our attempts to quantify the cftr-knockdown failed as none of the
tested commercially available antibodies against human CFTR
cross-reacted with the zebrafish protein, either in whole-mount
immunostaining or by western blotting. Nevertheless, the lack of
CFTR in cftr-morphants was easily observed by the failure of KV
expansion at the 10–11 s.s. This is in line with the fact that in
mutants homozygous for cftrpd1049 allele (null mutation) KV
inflation does not occur and those homozygous for the cftrpd1048
allele (missense mutation) have small KVs (Navis et al., 2013).
Knowing that the absence of CFTR does not affect the apical-basal
polarization, nor the ciliogenesis of the KV cells (Navis et al.,
2013), our data clearly supports its essential role in the KV inflation.
Fig. 5. The zebrafish KV as a model organ for CFTR stimulation in ADPKD cysts. (A,B) In WT embryos, the KV inflation is ensured by the CFTR-mediated
transport of Cl− and by the subsequentmovement of water towards the organ lumen (A). In KVepithelial cells (B), Polycystin-2 (PC2) located at the cilia membrane
allows the entrance of Ca2+ when stimulated by the luminal fluid-flow. This ciliary wave activates the Ca2+ release from the ER pools, in a Polycystin-2-dependent
manner, initiating a Ca2+-signaling of unknown effectors. Through inhibition of adenylyl cyclases 5 and 6 (AC5/AC6) and activation of phosphodiesterase 1A
(PDE1A), the Ca2+ transients maintain the basal intracellular levels of cAMP required for the normal rate of CFTR activity. (C,D) Mimicking ADPKD cysts, the
pkd2-knockdown enhances CFTR-mediated ion and fluid secretion into the KV, resulting in its significant enlargement (C). The reduced Ca2+ oscillations
are expected to activate AC5/AC6 and inhibit PDE1A, raising the intracellular levels of cAMP and, thus, driving the overstimulation of CFTR (D). Ca2+ and
Polycystin-2 (red); Cl− and CFTR (green); cAMP (yellow); H2O (blue); AC5, AC6, and PDE1A (grey). Full black arrows – known activations; dashed lines and
arrows – expected inhibitions/activations; line and arrow widths are proportional to the expected level of activation.
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CFTR transports Cl− towards the lumen of KV driving the
movement of water across the KV epithelium (Fig. 5A and B).
Reduced levels of Polycystin-2 lead to CFTR-dependent over-
inflation of the KV
The relevance of the KV as a model for ADPKD cyst inflation is
highlighted by the fact that pkd2-morphants have significantly
larger KVs thanWT siblings. While not involving cell proliferation,
this KV dilation is due to more fluid secretion into the KV’s lumen
(Fig. 5C). According to Compagnon et al. (2014), more fluid
secretion into the KV drives cell shape modifications by enhancing
the intraluminal pressure. As expected, pkd2-morphants exhibited
significant differences in the shape of the cells facing the KV
lumen midplan, both anteriorly and posteriorly. Finally, we
pharmacologically demonstrate that, in a cell autonomous manner,
the KV enlargement observed in pkd2-morphants is mediated by
CFTR activity. Indeed, the volume of the pkd2-morphant KVs was
rescued by CFTR inhibition and was synergistically enlarged by
further stimulating CFTR.
We first used ouabain to block the CFTR activity as this was used
by others to prove that the KV expansion requires CFTR (Navis
et al., 2013). However, more than CFTR activity, ouabain affects the
ion transport in general, since it is a Na+/K+-ATPase inhibitor
(Lingrel, 2010). We, thus, tested the effect of CFTRinh-172. Our
data showed a strong effect of both molecules in rescuing the KV
lumen expansion of pkd2-morphants to volumes equivalent or,
even, smaller than WT embryos. These data strengthen the use of
KV as model system for the stimulation of CFTR in ADPKD
because, as already mentioned, CFTRinh-172 also slows down
in vitro cyst enlargement (Li et al., 2004). In the future, it will be
interesting to test the effect of other molecules that have been shown
to be effective in slowing down cystogenesis in ADPKD cellular
and animal models (Blazer-Yost et al., 2010; Li et al., 2004, 2012;
Yang et al., 2008; Yuajit et al., 2013, 2014). These experiments are
even more appealing given the fact that zebrafish CFTR responds to
many pharmacological activators and inhibitors of human CFTR
activity (Bagnat et al., 2010).
To potentiate CFTR, we used forskolin+IBMX. These molecules
are known to raise the cellular cAMP levels. Indeed, forskolin
stimulates all adenylyl cyclases (ACs) and IBMX globally inhibits
phosphodiesterases (PDEs). Therefore, as the activation of CFTR
demands its prior phosphorylation by PKA and, in turn, PKA
activity depends on the intracellular levels of cAMP, higher cAMP
levels lead to the activation of CFTR. Under our experimental
conditions, we verified that these two drugs act synergistically with
the knockdown of Polycystin-2 towards enlarging the KV luminal
volume. Our data suggest that just like forskolin+IBMX, the
knockdown of Polycystin-2 stimulates CFTR in KV epithelial cells
by raising the intracellular levels of cAMP. This brings the KV
model-organ closer to kidney cysts. Indeed, renal cAMP levels are
elevated in ADPKD mice models and in human cyst epithelial cells
and have been suggested as one possible reason for the stimulation
of CFTR (Pinto et al., 2012; Spirli et al., 2012; Wallace, 2011).
Several evidences point to persistent synthesis and less degradation
of cAMP in ADPKD tissues (Pinto et al., 2012; Torres et al., 2012;
Wallace, 2011). A possible explanation arises from the activation
of the Ca2+-inhibited AC5 and AC6 and the inhibition of the
Ca2+-calmodulin-dependent PDE1 because of the reduced Ca2+
levels found in ADPKD cells (Wallace, 2011). Supporting our
model system, the knockdown of PDE1A aggravated the body
curvature and the renal phenotype of pkd2-morphant zebrafish
larvae, whereas the PDE1A overexpression partially rescued both
(Sussman et al., 2014). We have recently performed a tissue specific
microarray analysis (our unpublished observations) which showed
that KV epithelial cells express endogenously AC5, AC6a and
AC6b and PDE1A. Taken all together, we propose that as in kidney
cysts, in KV cells the drop of the intracellular Ca2+ levels caused by
the knockdown of Polycystin-2, leads to the activation of AC5 and
AC6 and to the inhibition of PDE1A, raising the levels of cAMP
and, thus, activating CFTR (Fig. 5D). Future studies are required to
further support this mechanistic overlap between KV development
and renal cystogenesis.
An important question for the ADPKD field is the time point at
which CFTR is activated during cystogenesis and whether this is
different when the disease-causing mutation affects pkd1 or pkd2.
Indeed, pkd1 mutations are associated with significantly more
severe disease, triggering cystogenesis earlier in patients’ lives
(Cornec-Le Gall et al., 2013). Although we cannot solve this
problem with our model yet, we hope to contribute to it in a near
future. As in kidney cells, Polycystin-2 in zebrafish KV cells
is expected to complex with a Polycystin-1 paralogue, the
Polycystin-1-like-1. This is the Polycystin-2 partner in medaka
KV (Kamura et al., 2011) and in mouse node (Field et al., 2011).
Once this missing piece in the puzzle has been found, we will be
able to compare the KV inflation dynamics of pkd1l1-morphants
with that of pkd2-morphants. So far, we were able to identify the
time point at which CFTR turns to be overstimulated in pkd2-
morphants, which was at the 3 s.s.
In conclusion, we show good evidence to consider zebrafish KV
an appropriate model system to study the mechanisms involved in
the stimulation of CFTR upon the lack of Polycystin-2. Allowing
the measurement of its volume as a live readout, it offers an
excellent in vivo model for screening compounds and genes that
may slow down cyst enlargement through CFTR inhibition.
MATERIALS AND METHODS
Fish strains
WT, ras:GFP transgenic (Cooper et al., 2005) and cuptc321 mutant zebrafish
lines, all of AB background, were maintained at 28°C. The latter was
outcrossed with foxj1a:GFP transgenic line of Tupfel long fin background
and, from these, only cup+/−;foxj1a:GFP were kept. Embryos obtained from
incrosses were incubated in E3 medium at 25°C or 28°C and staged as
described elsewhere (Kimmel et al., 1995). All procedures were approved by
the Portuguese Direcção Geral de Veterinária and Instituto Gulbenkian de
Ciência (IGC) ethics committee.
MO microinjections
The knockdown of pkd2 and cftr was induced by injecting one-cell stage
embryos with 1.8 and 1.6 ng of the translational blocking morpholinos
pkd2-augMO (Schottenfeld et al., 2007; Sun et al., 2004) and cftr-augMO
(5′-TCCTCCACAGGTGATCTCTGCATCC-3′), respectively. 1.8 ng of a
pkd2-mismatchMO was used as control. All morpholinos were purchased
from Gene Tools LLC (Philomath, USA). To target the knockdown of
Polycystin-2 to DFCs, pkd2-augMO was diluted in 1:4 (v/v) rhodamine-
dextran Mr 10,000 solution (Sigma-Aldrich, USA) and injected (4 ng and
9 ng) into the yolk in mid-blastula stage embryos as previously described
(Essner et al., 2005).
Heart laterality scoring
The heart jogging was evaluated at 30 hpf by observing the embryos from
their ventral side, using a stereoscope (SMZ745, Nikon Corporation, Japan).
In situ hybridization
Whole-mount in situ hybridizations were performed as before (Sampaio
et al., 2014). A fragment of cftr and pkd2 zebrafish genes
(ENSDART00000020412 and ENSDART00000020412, respectively)
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were amplified by PCR. The anti-sense RNA probes were transcribed using
SP6 RNA polymerase.
Immunofluorescence on whole-mount embryos
Dechorionated 10–11 s.s. embryos and those grown until 36 hpf (incubated
in 0.1 mM 1-phenyl-2-thiourea to avoid pigmentation) were fixed in 80:20
(v/v) methanol:DMSO for 1 min and rehydrated in sequential incubations in
crescent dilutions of methanol in PBS. The latter ones were further
incubated with Proteinase K (10 µg/ml) for 15 min at RT. After
permeabilization and blocking, embryos were incubated overnight at 4°C
with anti-Polycystin-2 polyclonal antibody (1:200; GTX113802, GeneTex,
USA) and, subsequently, with anti-acetylated α-tubulin (1:400; T7451,
Sigma) and anti-γ-tubulin (1:100; C-20, Santa Cruz Biotechnology,
Germany) monoclonal antibodies. Some embryos were incubated with
Alexa Fluor 488 phalloidin (1:100; Molecular Probes, USA) for actin
cytoskeleton evaluation. Alexa Fluor 488, 546 or 647 conjugated secondary
antibodies (1:500; Molecular Probes) were used. Nuclei were stained with
DAPI. Flat-mounted embryos were analyzed with confocal fluorescent
microscopy (Zeiss LSM710) and their whole KVs were scanned with
z-sections of 0.5 µm. Movies were analyzed using ImageJ. Selected stacks
were used to count the number of KV cilia.
Live-imaging in zebrafish KV
Embryos were mounted in a 2% (w/v) agarose mold and covered with E3
medium. For volumes evaluation, the whole KVs of 10–11 s.s. ras:GFP
transgenic embryoswere scanned by confocal-livemicroscopy, with z-sections
of 0.5 µm and acquisition rate lower than 1 frame per second. These stackswere
also used to count the number of KV-lining cells. To evaluate theKV-inflation
dynamics, the KV midplan of AB embryos was followed along development,
from1 to 4 s.s., by lightmicroscopy (NikonEclipse Ti-U invertedmicroscope),
under a 100×/1.30 NA oil immersion objective lens and recorded the images
with a FASTCAM-MC2 camera (Photron Europe Limited, UK) controlled
with Photron FASTCAMViewer software. Using the ImageJ plugin Measure
Stack, the KV was delineated and its luminal area was measured in all focal
planes. The volume resulted from the sum of the measurements of all focal
planes. The average values are referred to as KVvolume.
Cell shape evaluation
Selected stacks of embryos immunostained for actin cytoskeleton were
analyzed in Amira for 3D (FEI, USA) for cellular measurements (length,
width and height) in the KVmidplane. Cell apical surface area was given by
the product of cellular width and height values.
Pharmacological treatments
Stock solutions: 10 mM forskolin (Sigma), 100 mM IBMX (3-isobutyl-1-
methylxanthine; Sigma) and 10 mM CFTRinh-172 (CF Foundation
Therapeuticals), all in DMSO; and 1 mM ouabain (Sigma) in water.
Embryos were treated at 10 μM forskolin, 40 μM IBMX, 30 µM CFTRinh-
172 and 5 μM ouabain in E3 from 6 s.s. onwards.
Statistics
Differences were analyzed for statistical significance using Student’s t-test
in Prism (Graphpad, USA), being considered as statistically significant
when P<0.05. Results are expressed as mean±standard deviations (s.d.) of n
observations.
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Kramer-Zucker, A. G. (2008). The subcellular localization of TRPP2 modulates
its function. J. Am. Soc. Nephrol. 19, 1342-1351.
Gainullin, V. G., Hopp, K., Ward, C. J., Hommerding, C. J. and Harris, P. C.
(2015). Polycystin-1 maturation requires polycystin-2 in a dose-dependent
manner. J. Clin. Invest. 125, 607-620.
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